Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy

NCT06989541 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT06989541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06989541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
May 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypogammaglobulinemia, acquired